Clinical Social Workers in Fallsburg, NY Accepting Medicare
2 Clinical Social Workers found. Showing 1 - 2
 Ms. Gwen Billups-newton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15 Old Falls Road, Benjamin Coson Elementary, Fallsburg, NY 12733 Phone: 845-434-4110 Fax: 845-434-0871 |
Mrs. Michelle Marie Sager, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 Brickman Road, Fallsburg, NY 12733 Phone: 845-434-6800 Fax: 845-434-0118 |
News Archive
Researchers develop detailed map of protein-protein interactions between SARS-CoV-2 and the host
By conducting a state-of-the-art interactome study between SARS-CoV-2 and host cells, researchers from the University of Texas MD Anderson Cancer Center in Houston identified 437 human proteins as the high-confidence interacting proteins – with substantial implications for understanding coronavirus disease 2019 (COVID-19) pathology and potential treatments.
Scientists discover recurring pattern of more than 13,000 epigenetic alterations in young tumours
​Tumourigenesis is driven by genetic alterations and by changes in the epigenome, for instance by the addition of methyl groups to cytosine bases in the DNA. A deeper understanding of the interaction between the genetic and epigenetic mechanisms is critical for the selection of tumour biomarkers and for the future development of therapies. Human tumour specimens and cell lines however contain a plethora of genetic and epigenetic changes, which complicate data analysis.
GE Healthcare sells its Catalog Radiochemicals, SPA reagents and Cytostar-T plate product lines
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare's 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay (SPA) reagents and Cytostar-T plate product lines.
Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
› Verified 1 days ago